Carlsmed, Inc.
Carlsmed, Inc. is listed today as Carlsmed, Inc.: market value, financials and filings are on its company page.
Funding rounds
3 counted as startup funding. Open the number of investors for the round's details.
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| Mar 2024 | $65 M | No. 3 | $50 to $250 million | equity | SEC | |
| Apr 2022 | $30 M | No. 2 | $10 to $50 million | equity | SEC | |
| Dec 2020 | $13 M | No. 1 | $10 to $50 million | equity | SEC |
Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
Carlsmed, Inc. chose not to state its revenue in its newest notice of a funding round (Feb 2025).
SEC Form D · Feb 2025
The industry group it chose in its notices: Biotechnology.
SEC Form D · Feb 2025
That is all the official record says: Carlsmed, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.
Products and services#
No products or services of Carlsmed, Inc. are on record.
Investors#
10 named in official filings. Open an investor to see everything it has backed.
| Investor | Kind | Amount | Round | Role | Source |
|---|---|---|---|---|---|
| B Capital Global Growth III, L.P. | Fund or asset manager | not stated | not stated | Held Series B and C preferred stock, 10% owner (Form 3, 2025) | SEC Form 3 |
| B Capital Group Management, L.P. | Fund or asset manager | not stated | not stated | Held Series B and C preferred stock, 10% owner (Form 3, 2025) | SEC Form 3 |
| B Capital Healthcare I, L.P. | Fund or asset manager | not stated | not stated | Held Series B and C preferred stock, 10% owner (Form 3, 2025) | SEC Form 3 |
| Hornet Co-Invest Investors, Ltd. | Fund or asset manager | not stated | not stated | Held Series B and C preferred stock, 10% owner (Form 3, 2025) | SEC Form 3 |
| Hornet Co-Invest, LP | Fund or asset manager | not stated | not stated | Held Series B and C preferred stock, 10% owner (Form 3, 2025) | SEC Form 3 |
| Kevin Sidow | Person | not stated | not stated | Held Series B preferred stock, director (Form 3, 2025) | SEC Form 3 |
| Michael Cordonnier | Person | not stated | not stated | Held Series B preferred stock, director (Form 3, 2025) | SEC Form 3 |
| Niall Casey | Person | not stated | not stated | Held Series B preferred stock, director (Form 3, 2025) | SEC Form 3 |
| Presidio Management Group XII, L.L.C. | Fund or asset manager | not stated | not stated | Held Series A, B and C preferred stock, 10% owner (Form 3, 2025) | SEC Form 3 |
| U.S. Venture Partners XII, L.P. | Venture capital | not stated | not stated | Held Series A, B and C preferred stock, 10% owner (Form 3, 2025) | SEC Form 3 |
Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 3 rounds above had up to 50 investors.
Largest shareholders today
Institutions holding Carlsmed, Inc. shares, as of Sep 30, 2026.
- Parkman Healthcare Partners LLC$11 M2.85%
- Janus Henderson Group Ltd.$10 M2.65%
- BlackRock, Inc.$8 M2.12%
- Pier Capital, LLC$7 M1.89%
- Cadian Capital Management, LP$7 M1.82%
- Point72 Asset Management, L.P.$7 M1.81%
- Vanguard Capital Management LLC$4 M1.03%
- Palumbo Wealth Management LLC$4 M0.97%
- Russell Investments Group, Ltd.$4 M0.94%
- Geode Capital Management, LLC$3 M0.86%
- D. E. Shaw & Co., Inc.$2 M0.55%
- State Street Corp$2 M0.50%
- AQR Capital Management LLC$1 M0.32%
- Schonfeld Strategic Advisors LLC$1 M0.29%
- Tocqueville Asset Management L.P.$1 M0.29%
Source: SEC Form 13F holdings reports · as of Sep 30, 2026. Value held and share of the company. All holders are on the company page.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| Durall Scott | Executive officer | Feb 2025 |
| Leonard Greenstein | Executive officer | Feb 2025 |
| Michael Cordonnier | Executive officer | Feb 2025 |
| Niall Casey | Executive officer | Feb 2025 |
| Shariq Hussain | Executive officer | Feb 2025 |
| Sharon Schulzki | Executive officer | Feb 2025 |
| Alexander Arrow | Executive officer | Apr 2022 |
| Mark Singer | Executive officer | Apr 2022 |
| Justin Esterberg | Executive officer | Dec 2020 |
| Jonathan Root | Director | Feb 2025 |
| Kevin O'Boyle | Director | Feb 2025 |
| Kevin Sidow | Director | Feb 2025 |
| Michael Cordonnier | Director | Feb 2025 |
| Niall Casey | Director | Feb 2025 |
| Philip Young | Director | Feb 2025 |
| Robert Mittendorff | Director | Feb 2025 |
| Jonathon Root | Director | Dec 2020 |
Went public since 2025. Its SEC number is that of a company listed on a stock exchange.